James (Jim) Gale has a reputable 35 years of healthcare investing and financial experience. Being an expert in the trade, Jim’s healthcare industry and financial mindset are important to the future success of Juno Pharmaceuticals Canada.

Currently serving as the Founding Partner & Managing Director at Signet Healthcare Partners where he’s been for 24 years, Jim has established himself as an industry leader. Furthermore, Jim resides as the Chairman of the Board for Bionpharma Inc., Lead Director of Knight Therapeutics Inc., and maintains a spot on the Board of Directors for five Signet portfolio companies including Juno Canada. Jim received his Master of Business Administration from the University of Chicago.